School of Medicine
Showing 31-40 of 49 Results
-
Kenneth Mahaffey
Professor of Medicine (Cardiovascular Medicine)
BioClinical Focus: Cardiovascular Medicine: Atrial Fibrillation; Chronic CAD; ACS;
Research Focus:
My primary research interest is the design and conduct of multicenter clinical trials and analyses of important clinical cardiac issues using large patient databases. My research focuses on novel anticoagulation agents for the treatment of acute coronary syndromes and atrial fibrillation, the study of agents targeted to protect the myocardium during reperfusion therapy for acute myocardial infarction, and the evaluation of cardiovascular safety of diabetic therapies. I am also interested in the methodology of clinical trials. Current research activities include standardization of the definition of myocardial infarction used in clinical trials, the adjudication of suspected clinical endpoint events by Clinical Event Committees (CEC), and the efficient operational conduct of large multinational clinical trials.
Administrative Focus: Associate Dean, Clinical Research School of Medicine; Vice Chair of Clinical Research Department of Medicine; Director Stanford Center for Clinical Research; Member of the Stanford IRB
Professional Training:
1985 Stanford University, BS Chemistry
1989 University of Washington, MD
1993 University of Arizona, Internship/Residency/Chief Residency
1996 Duke University, Fellowship in Cardiology
1996 Duke University, Faculty in Cardiology
2013 Stanford University, Faculty Cardiovascular Medicine -
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
-
Daria Mochly-Rosen
George D. Smith Professor of Translational Medicine
Current Research and Scholarly InterestsTwo areas: 1. Using rationally-designed peptide inhibitors to study protein-protein interactions in cell signaling. Focus: protein kinase C in heart and large GTPases regulating mitochondrial dynamics in neurodegdenration. 2. Using small molecules (identified in a high throughput screens and synthetic chemistry) as activators and inhibitors of aldehyde dehydrogenases, a family of detoxifying enzymes, and glucose-6-phoshate dehydrogenase, in normal cells and in models of human diseases.
-
Margaret Over, MMS, PA-C
Adjunct Clinical Instructor, Educational Programs and Services (EPS)
BioMargaret (Maggie) Over, MMS, PA-C is a board-certified physician assistant practicing obstetrics and gynecology at Stanford Medicine Partners Ob/Gyn in Pleasanton. She received a Master’s degree in Medical Science in Physician Assistant Studies at Midwestern University. Maggie enjoys being able to treat women throughout varying stages of life and is passionate about patient education. In her free time, she enjoys running, reading and spending time with her family.
-
Philip A. Pizzo, M.D.
David and Susan Heckerman Professor, Emeritus
BioPhilip Pizzo, MD, is the David and Susan Heckerman Professor Emeritus. Pizzo served as Dean of the Stanford School of Medicine from April 2001 to December 1, 2012. He was Founding Director of the Stanford Distinguished Careers Institute from 2012 - 2022. Pizzo began rabbinical studies at the Academy for Jewish Religion, California in 2022 and studies in Spiritual Care and Counseling at the Jewish Theological Seminary in 2024.
Dr. Pizzo career focused on the diagnosis, management, prevention and treatment of childhood cancers and the infectious complications that occur in children whose immune systems are compromised by cancer and AIDS. He has been a leader in academic medicine and in longevity and the future of higher education.
Pizzo received his MD degree with Honors and Distinction in Research from the University of Rochester in 1970 and completed an internship and residency at the Boston Children’s Hospital. He was a fellow in pediatric oncology at the National Cancer Institute (NCI) and served as head of the NCI’s infectious disease section, chief of pediatric oncology, and scientific director for the Division of Clinical Sciences between. Before joining Stanford in 2001, he was the physician-in-chief of Boston Children’s Hospital and Chair of the Department of Pediatrics at Harvard Medical School, where he was also the Thomas Morgan Rotch Professor of Pediatrics.
Dr. Pizzo is the author of more than 650 scientific articles and 16 books and monographs. He also served as Editor-in-Chief of Current Opinion in Pediatrics from 2012 - 2019. He co-led the National Academy of Medicine 2011 report Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research; and “Dying in America: Improving Quality and Honoring Individual Preferences at the End of Life” that was published in 2015.
Pizzo has received numerous awards and honors, including the Public Health Service Outstanding Service Medal in 1995, the Barbara Bohen Pfiefer Award for Scientific Excellence in 1991, the Elizabeth Kubler-Ross Award in 2008, the Ronald McDonald Charities “Award of Excellence” in 2009, and the John and Emma Bonica Public Service Award in 2013. He is the 2012 recipient of the John Howland Award, the highest honor for lifetime achievement bestowed by the American Pediatric Society. In 2019 he received the John Stearns Medal from the New York Academy of Medicine. Pizzo received the 2021 International Immunocompromised Host Society’s Lifetime Distinguished Career Award. He received the Dean’s Medal from the University of Rochester in 2023.
Pizzo has been elected to the Association of American Physicians, the American Society of Clinical Investigation, the American Pediatric Society, the National Academy of Medicine. He has served as Chair of the Association of Academic Health Centers and Chair of the Council of Deans of the Association of American Medical Colleges. He was elected to the Board of Directors of the American Society for Clinical Oncology and the Infectious Diseases Society of America. He was President of the International Immunocompromised Host Society between1998 – 2011, and he served on the Governing Board for the California Institute of Regenerative Medicine from 2004 - 2012. Pizzo was elected to the Board of Trustees of the University of Rochester from 2009 - 2022 and the Board of Overseers of Koc University in Istanbul, Turkey from 2010 - 2022. He served Academic Advisory Council for Merritt Hawkins between 2015 - 2022., and the Advisory Board to the Milken Institute Center on Aging from 2015 - 2022. He was elected to the Board of Directors of the Ludwig Institute for Cancer Research from 2012- 2022. In 2015 Pizzo was elected to the Board of Directors of Global Blood Therapeutics through 2023, and in 2019 he was elected to the Board of Directors of Hillel at Stanford through 2023. -
Kathleen M. Sakamoto
Shelagh Galligan Professor in the School of Medicine
Current Research and Scholarly InterestsMy research focuses on the molecular pathways that regulate normal and aberrant blood cell development, including acute leukemia and bone marrow failure syndromes. We are also studying novel drugs for treatment of cancer.
-
Paul Schmiedmayer
Lead Artificial Intelligence and Assistant Director of Digital Health, School of Medicine - MDRP'S - Biodesign Program
Research Engineer, School of Medicine - MDRP'S - Biodesign ProgramCurrent Research and Scholarly InterestsDr. Schmiedmayer's research investigates scalable, intelligent, data-driven systems that leverage patient data and connected devices to provide real-time, personalized healthcare. He aims to validate these solutions by deploying AI-based models on resource-constrained, patient-facing devices, such as smartphones and smart devices, ensuring that personalized medicine is both cost-effective and privacy-preserving.
